Andy Chevigné and his team, RTI-5152-12 is postulated to boost the levels of opioid peptides that bind to classical opioid receptors during the Mind, leading to heightened painkilling activity. The LIH-RTI investigate groups proven a collaboration agreement and submitted a joint patent so